454 related articles for article (PubMed ID: 24854380)
41. Polymyalgia rheumatic (PMR): giant cell arteritis (GCA).
Kelly MC
Ir Med J; 2008; 101(7):222-4. PubMed ID: 18807817
[No Abstract] [Full Text] [Related]
42. Incidence of cardiovascular events in polymyalgia rheumatica and giant cell arteritis amongst an Asian population: Propensity score matched cohort study.
Kobayashi D; Suyama Y; Osugi Y; Arioka H; Takahashi O; Kuriyama N
Int J Rheum Dis; 2018 Jun; 21(6):1314-1321. PubMed ID: 29879315
[TBL] [Abstract][Full Text] [Related]
43. COVID-19 outcomes in giant cell arteritis and polymyalgia rheumatica versus rheumatoid arthritis: A national, multicenter, cohort study.
Vieira M; Comarmond C; Labreuche J; Mirouse A; Saadoun D; Richez C; Flipo RM; Hachulla E; Drumez E; Cacoub P;
J Autoimmun; 2022 Oct; 132():102868. PubMed ID: 35926375
[TBL] [Abstract][Full Text] [Related]
44. [Polymyalgia rheumatica and Giant Cell Arteritis - Update on Diagnosis and Therapy].
Becker M
Praxis (Bern 1994); 2020; 109(5):347-354. PubMed ID: 32233763
[TBL] [Abstract][Full Text] [Related]
45. Glucocorticoids for Management of Polymyalgia Rheumatica and Giant Cell Arteritis.
Matteson EL; Buttgereit F; Dejaco C; Dasgupta B
Rheum Dis Clin North Am; 2016 Feb; 42(1):75-90, viii. PubMed ID: 26611552
[TBL] [Abstract][Full Text] [Related]
46. Management of giant cell arteritis and polymyalgia rheumatica.
Meskimen S; Cook TD; Blake RL
Am Fam Physician; 2000 Apr; 61(7):2061-8, 2073. PubMed ID: 10779249
[TBL] [Abstract][Full Text] [Related]
47. The spectrum of polymyalgia rheumatica in northwestern Spain: incidence and analysis of variables associated with relapse in a 10 year study.
González-Gay MA; García-Porrúa C; Vázquez-Caruncho M; Dababneh A; Hajeer A; Ollier WE
J Rheumatol; 1999 Jun; 26(6):1326-32. PubMed ID: 10381051
[TBL] [Abstract][Full Text] [Related]
48. MMP-3 can distinguish isolated PMR from PMR with GCA: A retrospective study regarding PMR and GCA in Japan.
Fukui S; Nunokawa T; Kobayashi S; Kamei S; Yokogawa N; Takizawa Y; Shimada K; Sugii S; Setoguchi K
Mod Rheumatol; 2016; 26(2):259-64. PubMed ID: 26156043
[TBL] [Abstract][Full Text] [Related]
49. Serious infections in people with polymyalgia rheumatica (PMR) or giant cell arteritis (GCA): a time-trend national US study.
Singh JA; Cleveland JD
Clin Rheumatol; 2020 Nov; 39(11):3427-3438. PubMed ID: 32399772
[TBL] [Abstract][Full Text] [Related]
50. A prospective study of 287 patients with polymyalgia rheumatica and temporal arteritis: clinical and laboratory manifestations at onset of disease and at the time of diagnosis.
Myklebust G; Gran JT
Br J Rheumatol; 1996 Nov; 35(11):1161-8. PubMed ID: 8948307
[TBL] [Abstract][Full Text] [Related]
51. Risk of fracture among patients with polymyalgia rheumatica and giant cell arteritis: a population-based study.
Paskins Z; Whittle R; Sultan AA; Muller S; Blagojevic-Bucknall M; Helliwell T; Hider S; Roddy E; Mallen C
BMC Med; 2018 Jan; 16(1):4. PubMed ID: 29316928
[TBL] [Abstract][Full Text] [Related]
52. Prevalence and characteristics of subclinical giant cell arteritis in polymyalgia rheumatica.
De Miguel E; Macchioni P; Conticini E; Campochiaro C; Karalilova R; Monti S; Ponte C; Klinowski G; Monjo-Henry I; Falsetti P; Batalov Z; Tomelleri A; Hocevar A
Rheumatology (Oxford); 2024 Jan; 63(1):158-164. PubMed ID: 37129541
[TBL] [Abstract][Full Text] [Related]
53. Large-vessel involvement and aortic dilation in giant-cell arteritis. A multicenter study of 549 patients.
de Boysson H; Daumas A; Vautier M; Parienti JJ; Liozon E; Lambert M; Samson M; Ebbo M; Dumont A; Sultan A; Bonnotte B; Manrique A; Bienvenu B; Saadoun D; Aouba A
Autoimmun Rev; 2018 Apr; 17(4):391-398. PubMed ID: 29427822
[TBL] [Abstract][Full Text] [Related]
54. Monitoring and long-term management of giant cell arteritis and polymyalgia rheumatica.
Camellino D; Matteson EL; Buttgereit F; Dejaco C
Nat Rev Rheumatol; 2020 Sep; 16(9):481-495. PubMed ID: 32759996
[TBL] [Abstract][Full Text] [Related]
55. Update on the Treatment of Giant Cell Arteritis and Polymyalgia Rheumatica.
El Chami S; Springer JM
Rheum Dis Clin North Am; 2022 May; 48(2):493-506. PubMed ID: 35400374
[TBL] [Abstract][Full Text] [Related]
56. [Diagnosis and prognosis of polymyalgia rheumatica and giant cell arteritis].
ter Maaten JC; van de Kaa CA; Hoorntje SJ; Hillen HF
Ned Tijdschr Geneeskd; 1991 Jan; 135(2):64-8. PubMed ID: 1990310
[TBL] [Abstract][Full Text] [Related]
57. Giant cell arteritis and polymyalgia rheumatica after influenza vaccination: report of 10 cases and review of the literature.
Soriano A; Verrecchia E; Marinaro A; Giovinale M; Fonnesu C; Landolfi R; Manna R
Lupus; 2012 Feb; 21(2):153-7. PubMed ID: 22235046
[TBL] [Abstract][Full Text] [Related]
58. Giant cell arteritis and polymyalgia rheumatica: usefulness of vascular magnetic resonance imaging studies in the diagnosis of aortitis.
Narváez J; Narváez JA; Nolla JM; Sirvent E; Reina D; Valverde J
Rheumatology (Oxford); 2005 Apr; 44(4):479-83. PubMed ID: 15716321
[TBL] [Abstract][Full Text] [Related]
59. Serum markers associated with disease activity in giant cell arteritis and polymyalgia rheumatica.
van der Geest KS; Abdulahad WH; Rutgers A; Horst G; Bijzet J; Arends S; Roffel MP; Boots AM; Brouwer E
Rheumatology (Oxford); 2015 Aug; 54(8):1397-402. PubMed ID: 25724206
[TBL] [Abstract][Full Text] [Related]
60. Giant cell arteritis and polymyalgia rheumatica: clues to early diagnosis.
Dwolatzky T; Sonnenblick M; Nesher G
Geriatrics; 1997 Jun; 52(6):38-40, 43-4. PubMed ID: 9194789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
